Type B Time Determined Researcher (RTD-B)

Training, research and teaching experience
2023-present: Type B Time-Determined Researcher (RTD-B), Department of Systems Medicine, University of the Rome Tor Vergata Studies
2022-2023: Type A Time-Determined Researcher (RTD-A), International Medical University in Rome Unicamillus
2018-2022: Postdoctoral Research Activities (as Fellow and Assignor), Department of Systems Medicine, University of Rome Tor Vergata;
2011-2015: PhD in Neuroscience, Department of Systems Medicine, University of Rome Tor Vergata
2010-2011: Postgraduate Scholarship, Department of Neuroscience, University of Rome Tor Vergata
2010: Master's Degree magna cum laude in Cellular and Molecular Biology, University of Rome Tor Vergata
2007: Bachelor's Degree magna cum laude in Cellular and Molecular Biology, University of Rome Tor Vergata Claudia Ceci's research activity was initially aimed at neuronal differentiation and the role she specifies proteins (caspases) or exposure to potentially toxic agents (nickel) may have in this process. More recently, it has been dedicated to the study of new therapeutic strategies against different forms of cancer, such as carcinoma
of the bladder, melanoma and glioblastoma, in the form of compounds of natural origin and innovative biological drugs. Since 2018 he has been carrying out continuous teaching activities [Scientific Disciplinary Sector BIOS-11/A – Pharmacology] for the Courses of Degree in Pharmacy (in English), Medicine (in English and Italian), Three-year Health Professions. In 2022 he received the award “Italian Society of Pharmacology – Farmindustria”.

Bibliometric Indices
Total number of publications: 24
H-index: 15
Number of citations: 2277